跳至主要内容
临床试验/NCT03617471
NCT03617471已完成不适用

Pharmacokinetic Study of Paracetamol in Patients Over 80 Years Hospitalized to an Acute Geriatric Ward

Universitaire Ziekenhuizen KU Leuven2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2015年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
2
主要终点
Identification of the pharmacokinetic parameters: AUC

研究概览

简要总结

The goal of this exploratory study is the characterization of the pharmacokinetic (PK) profile of paracetamol in older patients and the specific PK (pharmacokinetic) variables associated with plasma exposure in this population.

详细描述

The goal of this exploratory study is the characterization of the pharmacokinetic profile of paracetamol in older patients and the specific PK variables associated with plasma exposure in this population. The primary endpoint is the identification of the pharmacokinetic parameters: area under the curve (AUC), peak plasma concentration after administration of paracetamol (Cmax) and the time at which the Cmax is observed (Tmax) of paracetamol. The secondary endpoint consists of 3 sub-endpoints:

  1. The variability in plasma exposure: volume of distribution (Vd), clearance (Cl) and elimination half-life (t1/2)
  2. The association between the PK parameters and pathophysiological factors
  3. The correlation between PK parameters and clinical parameters.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
80 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • a minimum age of 80 years
  • admission to the acute geriatrics ward
  • oral intake of paracetamol 1000 milligram (mg) in tablet form tid
  • a steady state situation (defined as at least 4 consecutive intakes of paracetamol before sampling)

排除标准

  • palliative care setting with downgrading of care

结局指标

主要结局

Identification of the pharmacokinetic parameters: AUC

时间窗: 8 hours (= during 1 dosing interval at steady state)

Area under the curve (AUC)

Identification of the pharmacokinetic parameters: Cmax

时间窗: 8 hours (= during 1 dosing interval at steady state)

Peak plasma concentration after administration of paracetamol (Cmax)

Identification of the pharmacokinetic parameters: Tmax

时间窗: 8 hours (= during 1 dosing interval at steady state)

The time at which the Cmax is observed (Tmax) of paracetamol

次要结局

  • Variability in plasma exposure: t1/2(8 hours (= during 1 dosing interval at steady state))
  • Variability in plasma exposure: Vd(8 hours (= during 1 dosing interval at steady state))
  • The association between the AUC (area under the curve) of paracetamol and patient related factors.(8 hours (= during 1 dosing interval at steady state))
  • Correlation between immuno assay method and the Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to determine paracetamol concentrations in serum(8 hours (= during 1 dosing interval at steady state))
  • Variability in plasma exposure: Cl(8 hours (= during 1 dosing interval at steady state))
  • The association between the AUC (area under the curve) of paracetamol and pain scores.(8 hours (= during 1 dosing interval at steady state))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Isabelle Spriet

PharmD, PhD

Universitaire Ziekenhuizen KU Leuven

研究点 (2)

Loading locations...

相似试验